Efficacy and Tolerability of Peginterferon <i>α</i>-2a and Peginterferon <i>α</i>-2b, Both plus Ribavirin, for Chronic Hepatitis C: A Meta-Analysis of Randomized Controlled Trials

<table class="table-group" width="800px"><tr class="fig-image" id="a"><td><img alt="739029.fig.003a" src="https://static.hindawi.com/articles/grp/volume-2013/739029/figures/739029.fig.003a.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(a) </b>RVR rate comparison</td></tr></table></td></tr><tr class="fig-image" id="b"><td><img alt="739029.fig.003b" src="https://static.hindawi.com/articles/grp/volume-2013/739029/figures/739029.fig.003b.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(b) </b>EVR rate comparison</td></tr></table></td></tr><tr class="fig-image" id="c"><td><img alt="739029.fig.003c" src="https://static.hindawi.com/articles/grp/volume-2013/739029/figures/739029.fig.003c.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(c) </b>ETR rate comparison</td></tr></table></td></tr></table>

<table>The RVR, EVR, and ETR rates of CHC patients treated with the two regimens. </table>

Gastroenterology Research and Practice

fig3

Figure 3

Figure 3: Efficacy and Tolerability of Peginterferon <i>α</i>-2a and Peginterferon <i>α</i>-2b, Both plus Ribavirin, for Chronic Hepatitis C: A Meta-Analysis of Randomized Controlled Trials 

Figure 3 | Efficacy and Tolerability of Peginterferon α-2a and Peginterferon α-2b, Both plus Ribavirin, for Chronic Hepatitis C: A Meta-Analysis of Randomized Controlled Trials 